Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01581866 · ClinicalTrials.gov registry record · Phase 1
Bioequivalence Study of Ziprasidone HCL Capsules, 20 mg Under Fasting Conditions
A Phase 1 study, sponsored by Dr. Reddy's Laboratories Limited.
- Completed
- Registry status
- Phase 1
- Development phase
- 56
- Enrollment target
NCT01581866 is a Phase 1 study that has completed, run by Dr. Reddy's Laboratories Limited. The registered enrollment target is 56 participants.
The verdict
NCT01581866, a Phase 1 study, has completed, sponsored by Dr. Reddy's Laboratories Limited.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 56 participants
- Enrollment target
Study Summary
The objective of this study is to compare the rate and extent of absorption of ziprasidone 20 mg capsules versus Geodon 20 mg capsules under fasting conditions.
Interventions
- DRUG Ziprasidone Hydrochloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2004-11 |
| Est. Completion | 2005-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01581866
The ClinicalTrials.gov registry entry for NCT01581866 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dr. Reddy's Laboratories Limited, which has 52 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ziprasidone Hydrochloride is the first listed.
NCT01581866 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01581866 about?
NCT01581866 is a clinical study titled "Bioequivalence Study of Ziprasidone HCL Capsules, 20 mg Under Fasting Conditions". The objective of this study is to compare the rate and extent of absorption of ziprasidone 20 mg capsules versus Geodon 20 mg capsules under fasting conditions.
What is the current status of trial NCT01581866?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 56 participants. The study started on 2004-11. Estimated completion is 2005-01.
What interventions are being tested in trial NCT01581866?
The interventions under investigation include: Ziprasidone Hydrochloride (DRUG).
Who is sponsoring clinical trial NCT01581866?
This trial is sponsored by Dr. Reddy's Laboratories Limited, which has 52 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.